Table 5.
Variables | No-show vs 0 no-show Adjusted OR (95% CI) |
||
---|---|---|---|
In-person | Video | Telephone | |
Age | 0.98 (0.97, 0.98) | 0.99 (0.97, 1.00) | 0.98 (0.97, 0.98) |
Income (Unit = $100,000) | 1.00 (1.00, 1.00) | 0.72 (0.23, 2.27) | 0.71 (0.40, 1.28) |
Gender | |||
Men | 1.20 (1.07, 1.35) | 1.62 (0.93, 2.81) | 1.23 (0.98, 1.54) |
Transgender | 1.92 (1.28, 2.87) | 1.61 (0.18, 14.1) | 0.65 (0.20, 2.11) |
Women | Reference | Reference | Reference |
Race/ethnicity | |||
White | 0.83 (0.75, 0.92) | 0.93 (0.64, 1.34) | 0.91 (0.74, 1.12) |
Other | 0.52 (0.38, 0.71) | 0.34 (0.04, 2.67) | 0.41 (0.21, 0.80) |
Black | Reference | Reference | Reference |
Housing status | |||
Permanent/stable | 0.53 (0.46, 0.60) | 0.37 (0.20, 0.69) | 0.80 (0.52, 1.23) |
Temporary/unstable | Reference | Reference | Reference |
HIV risk factor | |||
MSM | 0.82 (0.73, 0.92) | 0.68 (0.41, 1.13) | 0.81 (0.64, 1.02) |
Other | 0.93 (0.76, 1.14) | 1.05 (0.51, 2.18) | 1.32 (0.88, 1.97) |
Heterosexual | Reference | Reference | Reference |
aLogistic regression model using generalized estimating equations accounting for repeat measures in individuals and within
bBold denotes statistical significance (p < 0.05)
cTransgender includes individuals transgender, transgender male-to-female, and transgender female-to-male
dOther race includes Asian, Native Hawaiian/Pacific Islander, American Indian or Alaska Native, and Other (including mixed race)
eOther risk factor includes Injection drug use (IDU), hemophilia/coagulation disorder, receipt of blood transfusion, blood components, or tissue, perinatal transmission, and MSM/IDU